{"id":4055,"date":"2026-07-02T17:09:56","date_gmt":"2026-07-02T15:09:56","guid":{"rendered":"https:\/\/hepatoscope.com\/?p=4055"},"modified":"2026-07-02T17:22:42","modified_gmt":"2026-07-02T15:22:42","slug":"understanding-hepatoscope-derived-fat-fraction-hdff-a-breakthrough-in-bedside-liver-care","status":"publish","type":"post","link":"https:\/\/hepatoscope.com\/fr\/understanding-hepatoscope-derived-fat-fraction-hdff-a-breakthrough-in-bedside-liver-care\/","title":{"rendered":"Understanding Hepatoscope-Derived Fat Fraction (HDFF): A Breakthrough in Bedside Liver Care"},"content":{"rendered":"\n<article>\n    <h1>Understanding Hepatoscope-Derived Fat Fraction (HDFF): A Breakthrough in Bedside Liver Care<\/h1>\n    \n    <p>Quantitative assessment of liver fat has traditionally required Magnetic Resonance Imaging (MRI)\u2014a costly and often inaccessible diagnostic option for many patients . However, with the FDA 510(k) clearance of E-Scopics&rsquo; new <strong>Hepatoscope-Derived Fat Fraction (HDFF)<\/strong> technology, point-of-care liver assessment is undergoing a significant paradigm shift .<\/p>\n    \n    <hr \/>\n    \n    <h2>What is Hepatoscope-Derived Fat Fraction (HDFF)?<\/h2>\n    <p>HDFF is an objective, quantitative biomarker designed to estimate intra-hepatic fat directly at the point of care . By combining foundational quantitative ultrasound parameters\u2014specifically ultrasound attenuation and backscattering coefficients \u2014HDFF provides an accessible tool for the non-invasive assessment and ongoing clinical management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) .<\/p>\n    \n    <h2>Why HDFF is a Breakthrough for Non-Invasive Liver Assessment<\/h2>\n    \n    <h3>1. MRI-Level Accuracy at Ultrasound Speed<\/h3>\n    <p>While conventional ultrasound typically only provides qualitative information regarding the presence of fatty liver disease , HDFF delivers an objective percentage-based measurement in seconds . Clinically validated against the imaging gold standard, HDFF demonstrated an impressive 0.93 correlation coefficient with the MRI-PDFF reference standard . This brings advanced diagnostic confidence directly into routine bedside clinical workflows .<\/p>\n    \n    <h3>2. A Unified Ultraportable Solution (Steatosis + Fibrosis)<\/h3>\n    <p>The Hepatoscope stands out as the only ultraportable solution on the market that combines an FDA-cleared Fat Fraction estimate with real-time 2D Transient Elastography . This unique integration empowers clinicians to comprehensively evaluate both <strong>Steatosis (liver fat)<\/strong> and <strong>Fibrosis (liver stiffness)<\/strong> simultaneously using a single, portable device during a routine examination .<\/p>\n    \n    <h3>3. Democratizing Access and Improving Practice Workflows<\/h3>\n    <p>By shifting quantitative fat measurements from a costly, delayed MRI suite to an immediate point-of-care encounter , HDFF helps primary care physicians, obesity medicine specialists, and endocrinologists identify liver disease early and monitor treatment response more effectively . This is particularly valuable as new medical therapies demand scalable, objective tools to track real-time patient baselines .<\/p>\n    \n    <hr \/>\n    \n    <blockquote style=\"background-color: #f4f6f9; padding: 20px; border-left: 5px solid #0052cc; margin: 20px 0;\">\n        <strong>Optimize Your Clinical Workflow<\/strong><br \/>\n        Discover how the Hepatoscope brings advanced, non-invasive liver assessment directly to your practice . <a href=\"https:\/\/www.hepatoscope.com\/\" target=\"_blank\" rel=\"noopener\">Click here to schedule a 30-minute workflow assessment with our team today<\/a> .\n    <\/blockquote>\n<\/article>\n","protected":false},"excerpt":{"rendered":"<p>Understanding Hepatoscope-Derived Fat Fraction (HDFF): A Breakthrough in Bedside Liver Care Quantitative assessment of liver fat has traditionally required Magnetic Resonance Imaging (MRI)\u2014a costly and often inaccessible diagnostic option for many patients . However, with the FDA 510(k) clearance of E-Scopics&rsquo; new Hepatoscope-Derived Fat Fraction (HDFF) technology, point-of-care liver assessment is undergoing a significant paradigm [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[65,63],"tags":[],"class_list":["post-4055","post","type-post","status-publish","format-standard","hentry","category-blog-posts","category-news-media"],"acf":[],"_links":{"self":[{"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/posts\/4055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/comments?post=4055"}],"version-history":[{"count":1,"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/posts\/4055\/revisions"}],"predecessor-version":[{"id":4056,"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/posts\/4055\/revisions\/4056"}],"wp:attachment":[{"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/media?parent=4055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/categories?post=4055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hepatoscope.com\/fr\/wp-json\/wp\/v2\/tags?post=4055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}